Biopharmaceutical CMO And CRO Global Market Report 2024

Description

Biopharmaceutical contract manufacturing organizations (CMOs) and contract research organizations (CROs) are companies that offer outsourced services to biopharmaceutical companies. CMOs are responsible for the manufacturing and production of drugs, while CROs focus on research and development activities, including clinical trials and regulatory support. Both types of organizations help biopharmaceutical companies lower costs and accelerate the drug development process.

The primary products offered by biopharmaceutical CMOs and CROs include biologics and biosimilars. Biologics are complex medicines derived from living organisms, used to treat a range of diseases such as cancer, autoimmune disorders, and infectious diseases. These organizations provide various services, including contract manufacturing and contract research, with different methods of production, encompassing both mammalian and non-mammalian sources.

The biopharmaceutical CMO and CRO market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical CMO and CRO market statistics, including the biopharmaceutical CMO and CRO industry global market size, regional shares, competitors with the biopharmaceutical CMO and CRO market share, detailed biopharmaceutical CMO and CRO market segments, market trends, and opportunities, and any further data you may need to thrive in the biopharmaceutical CMO and CRO industry. These biopharmaceutical CMO and CRO market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biopharmaceutical CMO and CRO market size has grown strongly in recent years. It will grow from $31.29 billion in 2023 to $33.33 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be attributed to several factors, increased investment in biopharmaceutical research and development, rising demand for innovative therapies, a growing pipeline of biologics, significant expansion in the biopharmaceutical sector, and advancements in outsourcing strategies employed by pharmaceutical companies.

The biopharmaceutical CMO and CRO market size is expected to see strong growth in the next few years. It will grow to $43.11 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth during the forecast period can be attributed to several key factors, the growing trend of outsourcing drug development and manufacturing, a heightened focus on cost-effective production methods, expansion into new therapeutic areas and drug pipelines, increased demand for personalized medicine, and higher investments in biotechnology startups. Major trends expected to shape this period include a rise in the adoption of automated and high-throughput technologies, increased use of advanced analytics and AI in drug development, growing demand for cell and gene therapies, greater integration of digital technologies in clinical trials, and an uptick in the outsourcing of complex biopharmaceutical processes.

The biopharmaceutical CMO (Contract Manufacturing Organization) and CRO (Contract Research Organization) market is expected to grow due to increasing investments in research and development. These investments are driven by factors such as the need for innovation, competitive pressures, evolving market demands, and government incentives. Enhanced R&D funding allows CMOs and CROs to develop improved manufacturing techniques and research processes, boosting their capabilities and efficiency. This focus on innovation attracts and retains clients by offering advanced solutions while ensuring regulatory compliance. For example, Eurostat reported in December 2023 that EU expenditure on R&D rose to €352 billion ($384.42 billion) in 2022, a 6.34% increase from €331 billion ($361.48 billion) in the previous year. This growing R&D investment is fueling the expansion of the biopharmaceutical CMO and CRO market.

Leading companies in the biopharmaceutical CMO and CRO market are forming strategic partnerships to improve services, boost efficiencies, and speed up drug development for biopharmaceutical firms. Strategic partnerships involve companies combining their strengths and resources to achieve shared goals and mutual success. For example, in June 2024, Abzena plc, a UK-based biopharmaceutical company, entered into a partnership with Argonaut Manufacturing Services Inc., a US-based contract manufacturing organization (CMO), to offer integrated drug development and manufacturing solutions. This collaboration aims to deliver faster, end-to-end drug development and manufacturing processes, enhancing efficiency, lowering costs, and streamlining biopharmaceutical production for their clients.

In June 2024, Great Point Partners, a US-based investment firm, acquired Lyocontract GmbH for an undisclosed amount. This acquisition enables Great Point Partners to enhance Lyocontract's contract manufacturing capabilities, including aseptic liquid filling, freeze-drying, and injectable medicine packaging. Lyocontract GmbH, based in Germany, is a CDMO specializing in drug product contract development and manufacturing.

Major companies operating in the biopharmaceutical cmo and cro market are Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Eurofins Scientific SE, Lonza Group AG, Syneos Health Inc., Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Samsung Biologics Co. Ltd., CELLTRION INC., Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies UK Limited, Almac Group, Pharmaron Beijing Co. Ltd., Worldwide Clinical Trials, KBI Biopharma, Inotiv Inc., Caidya, Rentschler Biopharma SE, Celerion Inc., TFS HEALTHCARE LIMITED

North America was the largest region in the biopharmaceutical CMO and CRO market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo and cro market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biopharmaceutical cmo and cro market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical CMO and CRO market includes revenues earned by entities by providing services such as formulation development, quality control and assurance, clinical trial management, data management, and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical CMO And CRO Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical CMO and CRO market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical CMO and CRO ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical CMO and CRO market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Biologics; Biosimilars
2) By Service Type: Contract Manufacturing; Contract Research
3) By Source: Mammalian; Non-Mammalian
Companies Mentioned: Thermo Fisher Scientific Inc.; Boehringer Ingelheim International GmbH; Eurofins Scientific SE; Lonza Group AG; Syneos Health Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20492

1. Executive Summary

2. Biopharmaceutical CMO And CRO Market Characteristics

3. Biopharmaceutical CMO And CRO Market Trends And Strategies

4. Biopharmaceutical CMO And CRO Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Biopharmaceutical CMO And CRO Market Size and Growth

5.1. Global Biopharmaceutical CMO And CRO Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Biopharmaceutical CMO And CRO Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Biopharmaceutical CMO And CRO Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biopharmaceutical CMO And CRO Market Segmentation

6.1. Global Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Biologics
Biosimilars
6.2. Global Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Contract Manufacturing
Contract Research
6.3. Global Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Mammalian
Non-Mammalian

7. Biopharmaceutical CMO And CRO Market Regional And Country Analysis

7.1. Global Biopharmaceutical CMO And CRO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Biopharmaceutical CMO And CRO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biopharmaceutical CMO And CRO Market

8.1. Asia-Pacific Biopharmaceutical CMO And CRO Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biopharmaceutical CMO And CRO Market

9.1. China Biopharmaceutical CMO And CRO Market Overview
9.2. China Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biopharmaceutical CMO And CRO Market

10.1. India Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biopharmaceutical CMO And CRO Market

11.1. Japan Biopharmaceutical CMO And CRO Market Overview
11.2. Japan Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biopharmaceutical CMO And CRO Market

12.1. Australia Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biopharmaceutical CMO And CRO Market

13.1. Indonesia Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biopharmaceutical CMO And CRO Market

14.1. South Korea Biopharmaceutical CMO And CRO Market Overview
14.2. South Korea Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biopharmaceutical CMO And CRO Market

15.1. Western Europe Biopharmaceutical CMO And CRO Market Overview
15.2. Western Europe Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biopharmaceutical CMO And CRO Market

16.1. UK Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biopharmaceutical CMO And CRO Market

17.1. Germany Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biopharmaceutical CMO And CRO Market

18.1. France Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biopharmaceutical CMO And CRO Market

19.1. Italy Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biopharmaceutical CMO And CRO Market

20.1. Spain Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biopharmaceutical CMO And CRO Market

21.1. Eastern Europe Biopharmaceutical CMO And CRO Market Overview
21.2. Eastern Europe Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biopharmaceutical CMO And CRO Market

22.1. Russia Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biopharmaceutical CMO And CRO Market

23.1. North America Biopharmaceutical CMO And CRO Market Overview
23.2. North America Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biopharmaceutical CMO And CRO Market

24.1. USA Biopharmaceutical CMO And CRO Market Overview
24.2. USA Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biopharmaceutical CMO And CRO Market

25.1. Canada Biopharmaceutical CMO And CRO Market Overview
25.2. Canada Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biopharmaceutical CMO And CRO Market

26.1. South America Biopharmaceutical CMO And CRO Market Overview
26.2. South America Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biopharmaceutical CMO And CRO Market

27.1. Brazil Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biopharmaceutical CMO And CRO Market

28.1. Middle East Biopharmaceutical CMO And CRO Market Overview
28.2. Middle East Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biopharmaceutical CMO And CRO Market

29.1. Africa Biopharmaceutical CMO And CRO Market Overview
29.2. Africa Biopharmaceutical CMO And CRO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Biopharmaceutical CMO And CRO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Biopharmaceutical CMO And CRO Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biopharmaceutical CMO And CRO Market Competitive Landscape And Company Profiles

30.1. Biopharmaceutical CMO And CRO Market Competitive Landscape
30.2. Biopharmaceutical CMO And CRO Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Boehringer Ingelheim International GmbH
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Eurofins Scientific SE
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Lonza Group AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Syneos Health Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Biopharmaceutical CMO And CRO Market Other Major And Innovative Companies

31.1. Catalent Inc.
31.2. Charles River Laboratories International Inc.
31.3. Parexel International (MA) Corporation
31.4. Samsung Biologics Co. Ltd.
31.5. CELLTRION INC.
31.6. Medpace Holdings Inc.
31.7. Fujifilm Diosynth Biotechnologies UK Limited
31.8. Almac Group
31.9. Pharmaron Beijing Co. Ltd.
31.10. Worldwide Clinical Trials
31.11. KBI Biopharma
31.12. Inotiv Inc.
31.13. Caidya
31.14. Rentschler Biopharma SE
31.15. Celerion Inc.

32. Global Biopharmaceutical CMO And CRO Market Competitive Benchmarking

33. Global Biopharmaceutical CMO And CRO Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Biopharmaceutical CMO And CRO Market

35. Biopharmaceutical CMO And CRO Market Future Outlook and Potential Analysis

35.1 Biopharmaceutical CMO And CRO Market In 2028 - Countries Offering Most New Opportunities
35.2 Biopharmaceutical CMO And CRO Market In 2028 - Segments Offering Most New Opportunities
35.3 Biopharmaceutical CMO And CRO Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer